QUIPT HOME MEDICAL CORP (QIPT) Stock Fundamental Analysis
NASDAQ:QIPT - Nasdaq - CA74880P1045 - Common Stock - Currency: USD
Taking everything into account, QIPT scores 3 out of 10 in our fundamental rating. QIPT was compared to 102 industry peers in the Health Care Providers & Services industry. QIPT may be in some trouble as it scores bad on both profitability and health. QIPT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year QIPT has reported negative net income.
QIPT had a positive operating cash flow in the past year.
In the past 5 years QIPT reported 4 times negative net income.
Each year in the past 5 years QIPT had a positive operating cash flow.
1.2 Ratios
The Return On Assets of QIPT (-2.99%) is worse than 60.78% of its industry peers.
QIPT has a Return On Equity of -6.83%. This is comparable to the rest of the industry: QIPT outperforms 42.16% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.14%, QIPT is doing worse than 62.75% of the companies in the same industry.
QIPT had an Average Return On Invested Capital over the past 3 years of 2.55%. This is significantly below the industry average of 9.12%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.99% | ||
| ROE | -6.83% | ||
| ROIC | 0.14% |
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)2.55%
ROIC(5y)N/A
1.3 Margins
QIPT's Operating Margin of 0.14% is on the low side compared to the rest of the industry. QIPT is outperformed by 61.76% of its industry peers.
The Gross Margin of QIPT (71.56%) is better than 89.22% of its industry peers.
In the last couple of years the Gross Margin of QIPT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.14% | ||
| PM (TTM) | N/A | ||
| GM | 71.56% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
QIPT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, QIPT has more shares outstanding
The number of shares outstanding for QIPT has been increased compared to 5 years ago.
The debt/assets ratio for QIPT is higher compared to a year ago.
2.2 Solvency
QIPT has an Altman-Z score of 0.48. This is a bad value and indicates that QIPT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.48, QIPT is doing worse than 76.47% of the companies in the same industry.
The Debt to FCF ratio of QIPT is 4.91, which is a neutral value as it means it would take QIPT, 4.91 years of fcf income to pay off all of its debts.
QIPT's Debt to FCF ratio of 4.91 is fine compared to the rest of the industry. QIPT outperforms 65.69% of its industry peers.
A Debt/Equity ratio of 0.74 indicates that QIPT is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.74, QIPT is in line with its industry, outperforming 46.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 4.91 | ||
| Altman-Z | 0.48 |
ROIC/WACC0.02
WACC7.5%
2.3 Liquidity
A Current Ratio of 1.22 indicates that QIPT should not have too much problems paying its short term obligations.
QIPT has a worse Current ratio (1.22) than 63.73% of its industry peers.
QIPT has a Quick Ratio of 1.22. This is a bad value and indicates that QIPT is not financially healthy enough and could expect problems in meeting its short term obligations.
QIPT has a Quick ratio of 0.87. This is in the lower half of the industry: QIPT underperforms 75.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
QIPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -55.56%.
QIPT shows a decrease in Revenue. In the last year, the revenue decreased by -1.77%.
Measured over the past years, QIPT shows a very strong growth in Revenue. The Revenue has been growing by 32.16% on average per year.
EPS 1Y (TTM)-55.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)-1.77%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-6.15%
3.2 Future
The Earnings Per Share is expected to grow by 97.77% on average over the next years. This is a very strong growth
QIPT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.85% yearly.
EPS Next Y32%
EPS Next 2Y20.9%
EPS Next 3Y16.35%
EPS Next 5Y97.77%
Revenue Next Year-3.59%
Revenue Next 2Y0.8%
Revenue Next 3Y1.65%
Revenue Next 5Y21.85%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
QIPT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QIPT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QIPT indicates a rather cheap valuation: QIPT is cheaper than 95.10% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, QIPT is valued cheaply inside the industry as 96.08% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.49 | ||
| EV/EBITDA | 4.07 |
4.3 Compensation for Growth
QIPT's earnings are expected to grow with 16.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.9%
EPS Next 3Y16.35%
5. Dividend
5.1 Amount
No dividends for QIPT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.14
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners59.95%
Inst Owner Change5.97%
Ins Owners9.53%
Ins Owner Change54.32%
Market Cap92.21M
Analysts82.22
Price Target6.52 (204.67%)
Short Float %4.2%
Short Ratio11.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-45.98%
Min EPS beat(2)-124.09%
Max EPS beat(2)32.12%
EPS beat(4)1
Avg EPS beat(4)-255.78%
Min EPS beat(4)-540.96%
Max EPS beat(4)32.12%
EPS beat(8)1
Avg EPS beat(8)-522.14%
EPS beat(12)3
Avg EPS beat(12)-242.54%
EPS beat(16)4
Avg EPS beat(16)-226.56%
Revenue beat(2)0
Avg Revenue beat(2)-11.63%
Min Revenue beat(2)-20.53%
Max Revenue beat(2)-2.74%
Revenue beat(4)0
Avg Revenue beat(4)-7.82%
Min Revenue beat(4)-20.53%
Max Revenue beat(4)-2.74%
Revenue beat(8)1
Avg Revenue beat(8)-4.62%
Revenue beat(12)1
Avg Revenue beat(12)-4.57%
Revenue beat(16)2
Avg Revenue beat(16)-4.02%
PT rev (1m)4.89%
PT rev (3m)-2.23%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)100%
EPS NY rev (1m)0%
EPS NY rev (3m)-199.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.38 | ||
| P/FCF | 4.49 | ||
| P/OCF | 2.8 | ||
| P/B | 0.87 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.07 |
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.48
FCFY22.26%
OCF(TTM)0.76
OCFY35.73%
SpS5.61
BVpS2.47
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.99% | ||
| ROE | -6.83% | ||
| ROCE | 0.18% | ||
| ROIC | 0.14% | ||
| ROICexc | 0.15% | ||
| ROICexgc | 0.5% | ||
| OM | 0.14% | ||
| PM (TTM) | N/A | ||
| GM | 71.56% | ||
| FCFM | 8.48% |
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)2.55%
ROIC(5y)N/A
ROICexc(3y)2.81%
ROICexc(5y)N/A
ROICexgc(3y)9.78%
ROICexgc(5y)N/A
ROCE(3y)3.22%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
F-Score3
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 4.91 | ||
| Debt/EBITDA | 1.82 | ||
| Cap/Depr | 28.74% | ||
| Cap/Sales | 5.13% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 75.63% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 0.48 |
F-Score3
WACC7.5%
ROIC/WACC0.02
Cap/Depr(3y)26.65%
Cap/Depr(5y)21.79%
Cap/Sales(3y)4.61%
Cap/Sales(5y)3.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-55.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y32%
EPS Next 2Y20.9%
EPS Next 3Y16.35%
EPS Next 5Y97.77%
Revenue 1Y (TTM)-1.77%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-6.15%
Revenue Next Year-3.59%
Revenue Next 2Y0.8%
Revenue Next 3Y1.65%
Revenue Next 5Y21.85%
EBIT growth 1Y-93.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1704.97%
EBIT Next 3Y170.49%
EBIT Next 5Y154.85%
FCF growth 1Y23.94%
FCF growth 3Y22.49%
FCF growth 5Y24.98%
OCF growth 1Y26.48%
OCF growth 3Y23.7%
OCF growth 5Y33.42%